Liquid Biopsy in Advanced Colorectal Cancer: Clinical Applications of Different Analytes

Autor: Marco Donatello Delcuratolo, Andrea Modrego-Sánchez, Maristella Bungaro, Beatriz Antón-Pascual, Santiago Teran, Valentina Dipace, Silvia Novello, Rocio Garcia-Carbonero, Francesco Passiglia, Cristina Graválos-Castro

Publikováno v: Journal of Molecular Pathology, Vol 4, Iss 3, Pp 128-155 (2023)

Colorectal cancer is one of the most prevalent cancers nowadays. In the metastatic setting, diagnosis and treatment have relied on tumor tissue analysis. However, the different limitations of this approach have recently opened the door to the introdu

Externí odkaz: https://doaj.org/article/ef5052c039fe40a7b4f817d3098b8874

FGFR1 Amplification and Response to Neoadjuvant Anti-HER2 Treatment in Early HER2-Positive Breast Cancer

Autor: María Gaibar, Apolonia Novillo, Alicia Romero-Lorca, Diego Malón, Beatriz Antón, Amalia Moreno, Ana Fernández-Santander

Publikováno v: Pharmaceutics, Vol 14, Iss 2, p 242 (2022)

HER2-positive breast cancer (BC) is an aggressive subtype that affects 20–25% of BC patients. For these patients, neoadjuvant therapy is a good option that targets a pathological complete response (pCR) and more breast-conserving surgery. In effect

Externí odkaz: https://doaj.org/article/2b4348e3d6dc44aebcbca7300832cb98

Los Emblemata (Frankfurt, 1596) de Dionysius Lebeus Batillius: Clasicismo, Neoestoicismo, Calvinismo

Autor: Beatriz Antón Martínez

Publikováno v: Janus: Estudios sobre el Siglo de Oro, Vol 3, Pp 115-176 (2014)

The Emblemata (Frankfurt, 1596) of the Calvinist judge D. Lebeus Batillius, book that closes the Golden Age of French Emblematics, are detailed studied for the first time in light of the author’s biography and his relationship with the emblematist

Externí odkaz: https://doaj.org/article/74fdf9dd0b854cd5bea175ce0e39621c

HER2 and BARD1 Polymorphisms in Early HER2-Positive Breast Cancer Patients: Relationship with Response to Neoadjuvant Anti-HER2 Treatment

Autor: Apolonia Novillo, María Gaibar, Alicia Romero-Lorca, Diego Malón, Beatriz Antón, Amalia Moreno, Ana Fernández-Santander

Publikováno v: Cancers
Volume 15
Issue 3
Pages: 763

The addition to chemotherapy of anti-HER2 drugs such as trastuzumab or pertuzumab has improved outcomes in HER2-positive breast cancer patients. However, resistance to these drugs in some patients remains a major concern. This study examines the poss

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94204e28235903d61171f34dd0053b3d
https://doi.org/10.3390/cancers15030763

Genetic Variants of ANGPT1, CD39, FGF2 and MMP9 Linked to Clinical Outcome of Bevacizumab Plus Chemotherapy for Metastatic Colorectal Cancer

Autor: María Gaibar, Beatriz Antón, Miguel Galán, Apolonia Novillo, Ana Fernández-Santander, Alicia Romero-Lorca, Amalia Moreno, Diego Malón

Publikováno v: International Journal of Molecular Sciences
Volume 22
Issue 3
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
International Journal of Molecular Sciences, Vol 22, Iss 1381, p 1381 (2021)

Angiogenesis pathway genes show substantial genetic variability causing inter-individual differences in responses to anti-angiogenic drugs. We examined 20 single nucleotide polymorphisms (SNPs) in 13 of these genes to predict tumour response and clin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24bc6074b49f6e3c70391e1e83c0727e